Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug combinations
Biotech
Vir keeps pressure on Gilead with midphase hepatitis D data
Vir's hepatitis D therapy has shown efficacy in a phase 2 test, suggesting the cocktail may pose a threat to Gilead’s attempt in the market.
Nick Paul Taylor
Jun 5, 2024 8:52am
Gilead-Arcus' TIGIT gets high response in gastric cancer
Nov 7, 2023 9:40am
Faron's latest snapshot suggests antibody has leukemia potential
Jul 19, 2023 8:45am
HaemaLogix's myeloma drug boosts responses in Revlimid combo
Jun 29, 2023 9:10am
GSK gives early look at HIV bNAb's power
Oct 25, 2022 10:00am
New Merck lymphoma data could help patients without options
May 26, 2022 5:00pm
